| ¿µ¹® | obesity | ÇÑ±Û | ºñ¸¸Áõ |
|---|---|---|---|
| ¼³¸í | ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î üÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª üÁö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â üÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î ÇØ¼ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú üÁö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³´Ù. ºñ¸¸, ƯÈ÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, ƯÈ÷ ¼ºÀκ´À̶ó°í ÇÏ´Â ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â üÁßÀ» ÃøÁ¤ÇÏ´Â ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡ÇÏ´Â ÀÓ»óÀûÀÎ ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇÏ´Â ¹æ¹ýÀ̸ç [½ÅÀå(cm)£100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼ÁߣǥÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, ȯ°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù. |
||
| ¿µ¹® | VDRL(venereal disease research laboratory) | ÇÑ±Û | ¼ºº´ ¿¬±¸½ÇÇè½Ç |
|---|---|---|---|
| ¼³¸í | ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. |
||
| COI | Central Obesity Index; certificate of insurance; cost of illness |
|---|---|
| HHHO | hypotonia, hypomentia, hypogonadism, obesity [syndrome] |
| MO | macroorchidism; manually operated; Master of Obstetrics; Master of Osteopathy; medical officer; mesi... |
| MOMO | macrosomia-obesity-macrocephaly-ocular abnormalities [syndrome] |
| OB | obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici... |
| DIO | Diet-induced obesity |
|---|---|
| OHS | Obesity Hypoventilation Syndrome |
| %OB | obesity |
| ARCI | Addiction Research Center Inventory |
| AHCPR | Agency for Health Care Policy and Research |
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
|---|---|
| central obesity | The deposition of obesity around the trunk sparing the limbs. (27 Sep 1997) |
| risks, obesity-related | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness) (12 Dec 1998) |
| morbid obesity | Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition. Simple obesity, obesity resulting when caloric intake exceeds energy expenditure. (05 Mar 2000) |
| hypothalamic obesity with hypogonadism | A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms. Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism. Origin: L. Fr. G. Dys-, bad, + trophe, nourishment (05 Mar 2000) |
| diseases, obesity-related | Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| obesity | <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Origin: L. Obesus = fat (18 Nov 1997) |
| obesity index | Body weight divided by body volume. (05 Mar 2000) |
| obesity, morbid | The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. (12 Dec 1998) |
| obesity-related diseases | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| Venereal Disease Research Laboratory | <microbiology> A blood test used to diagnose syphilis. Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy. Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies). (12 Jan 1998) |
| Medical Research Council | <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom. It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases. (05 Jan 1998) |
| research | Careful, a diligent search, a close searching, studious inquiry or examination. (18 Nov 1997) |
| research, controlled | The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured. (12 Dec 1998) |
| research design | A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|